249 related articles for article (PubMed ID: 2768880)
1. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
Grosset JH; Baohang J; Noordeen SK
Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
[No Abstract] [Full Text] [Related]
2. Combined chemotherapy of multibacillary leprosy patients.
Samuel NM; Samuel S; Adiga RB
Nihon Rai Gakkai Zasshi; 1986; 55(3):65-71. PubMed ID: 3680070
[No Abstract] [Full Text] [Related]
3. Drug resistance and multi-drug therapy in leprosy.
Chatterjee BR
Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
[No Abstract] [Full Text] [Related]
4. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Chum HJ
Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
[No Abstract] [Full Text] [Related]
5. First assessment of the Malta Leprosy Eradication Project.
Leiker DL
Lepr Rev; 1986; 57 Suppl 3():42-6. PubMed ID: 3573959
[No Abstract] [Full Text] [Related]
6. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Depasquale G
Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
[No Abstract] [Full Text] [Related]
7. Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
Dietrich M; Wabitsch R
Lepr Rev; 1986; 57 Suppl 3():60-2. PubMed ID: 3573962
[No Abstract] [Full Text] [Related]
8. Combined chemotherapy of multibacillary leprosy of 6 months' duration.
Onsun N; Saylan T; Pattyn SR
Lepr Rev; 1986; 57 Suppl 3():124-6. PubMed ID: 3573952
[No Abstract] [Full Text] [Related]
9. Combinations of rifampicin and isoprodian in the treatment of Mycobacterium leprae infections in mice.
Matsuo Y; Utsunomiya S; Kajihara N; Kim SK
Nihon Rai Gakkai Zasshi; 1978; 47(1):43-7. PubMed ID: 701209
[No Abstract] [Full Text] [Related]
10. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
[TBL] [Abstract][Full Text] [Related]
11. [New drugs in the treatment of leprosy].
De Las Aguas JT
Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
[TBL] [Abstract][Full Text] [Related]
12. Multi-drug therapy in leprosy: an effective method of control.
Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Winsley BE; McDougall AC; Brown KE
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
[No Abstract] [Full Text] [Related]
14. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
15. Prothionamide and dapsone therapy in leprosy--a clinical study.
Kundu SK; Hazra SK; Chaudhury SK; Chatterjee B
Indian J Lepr; 1985; 57(1):90-6. PubMed ID: 3839829
[TBL] [Abstract][Full Text] [Related]
16. [Combination drug therapy in leprosy].
Terencio de las Aguas J
Acta Leprol; 1983; 1(3):143-50. PubMed ID: 6359802
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
Pereira V
Prax Pneumol; 1976 Sep; 30(9):584-7. PubMed ID: 967829
[No Abstract] [Full Text] [Related]
18. Failure of a prothionamide-containing oral antituberculosis regimen.
Langton ME; Cowie RL
S Afr Med J; 1985 Dec; 68(12):881. PubMed ID: 4071346
[TBL] [Abstract][Full Text] [Related]
19. The chemotherapy of leprosy. Part 1.
Ellard GA
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
[No Abstract] [Full Text] [Related]
20. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
